LAS: a software platform to support oncological data management.
about
HER2 activating mutations are targets for colorectal cancer treatmentThe genomic landscape of response to EGFR blockade in colorectal cancer.Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.
P2860
LAS: a software platform to support oncological data management.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
LAS: a software platform to support oncological data management.
@ast
LAS: a software platform to support oncological data management.
@en
type
label
LAS: a software platform to support oncological data management.
@ast
LAS: a software platform to support oncological data management.
@en
prefLabel
LAS: a software platform to support oncological data management.
@ast
LAS: a software platform to support oncological data management.
@en
P2093
P1476
LAS: a software platform to support oncological data management.
@en
P2093
Alberto Grand
Alessandro Fiori
Andrea Bertotti
P2888
P304
P356
10.1007/S10916-012-9891-6
P478
36 Suppl 1
P577
2012-11-02T00:00:00Z
P5875
P6179
1009324561